Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Update

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a significant growth in short interest in August. As of August 31st, there was short interest totaling 756 shares, a growth of 3,878.9% from the August 15th total of 19 shares. Based on an average daily trading volume, of 3,423 shares, the days-to-cover ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CZMWY shares. Zacks Research cut Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Morgan Stanley assumed coverage on Carl Zeiss Meditec in a report on Wednesday, September 2nd. They set an “underweight” rating on the stock. Finally, UBS Group cut Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday, August 11th. Two equities research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Strong Sell”.

Carl Zeiss Meditec Trading Up 0.5%

OTCMKTS CZMWY opened at $35.85 on Friday. The firm’s 50 day simple moving average is $35.00 and its 200 day simple moving average is $31.70. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $55.94.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.